The dumping syndrome global market report 2024 from The Business Research Company provides comprehensive market statistics, including global market size, regional shares, competitor market share, detailed segments, trends, and opportunities. This report offers an in-depth analysis of current and future industry scenarios, delivering a complete perspective for thriving in the industrial automation software market.
Dumping Syndrome Market, 2024 report by The Business Research Company offers comprehensive insights into the current state of the market and highlights future growth opportunities.
Market Size –
The dumping syndrome market size has grown rapidly in recent years. It will grow from $1.12 billion in 2023 to $1.24 billion in 2024 at a compound annual growth rate (CAGR) of 10.9%. The growth in the historic period can be attributed to gastric surgery procedures, increased prevalence of obesity, advancements in surgical techniques, improved diagnostic methods.
The dumping syndrome market size is expected to see strong growth in the next few years. It will grow to $1.81 billion in 2028 at a compound annual growth rate (CAGR) of 9.9%. The growth in the forecast period can be attributed to weight loss surgery trends, personalized treatment approaches, nutritional and dietary interventions, telemedicine and remote monitoring. Major trends in the forecast period include minimally invasive surgical techniques, data analytics and ai, increased collaboration, preventive measures.
Order your report now for swift delivery @
https://www.thebusinessresearchcompany.com/report/dumping-syndrome-global-market-report
Scope Of Dumping Syndrome Market
The Business Research Company’s reports encompass a wide range of information, including:
1. Market Size (Historic and Forecast): Analysis of the market’s historical performance and projections for future growth.
2. Drivers: Examination of the key factors propelling market growth.
3. Trends: Identification of emerging trends and patterns shaping the market landscape.
4. Key Segments: Breakdown of the market into its primary segments and their respective performance.
5. Focus Regions and Geographies: Insight into the most critical regions and geographical areas influencing the market.
6. Macro Economic Factors: Assessment of broader economic elements impacting the market.
Dumping Syndrome Market Overview
Market Drivers –
The rising prevalence of upper GI diseases is expected to propel the growth of the dumping syndrome market going forward. Upper gastrointestinal (GI) diseases refer to disorders affecting the upper part of the digestive system, including the esophagus, stomach and the first part of the small intestine (duodenum). Dumping syndrome is a condition that can occur after a person undergoes particular upper gastrointestinal (GI) surgeries, particularly those that involve the stomach, duodenum, or pyloric sphincter. For instance, in April 2023, according to the National Library of Medicine, a US-based medical library, Upper gastrointestinal bleeding (UGIB) is a frequent issue, with an estimated occurrence in 80 to 150 out of 100,000 individuals annually. The estimated mortality rates range from 2 to 15 percent. Upper gastrointestinal bleeding (UGIB) constitutes 75% of all cases of acute gastrointestinal (GI) bleeding. Therefore, the rising prevalence of upper GI diseases is driving the growth of the dumping syndrome market.
Market Trends –
Major companies operating in the dumping syndrome market are increasing their focus on introducing non-invasive tools for measuring gastric emptying to gain a competitive edge in the market. Non-invasive tools for measuring gastric emptying are diagnostic methods that assess the rate at which the stomach empties its contents into the small intestine without the need for invasive procedures. For instance, in September 2021, Cairn Diagnostics, a US-based life science company, launched the 13C-Spirulina Gastric Emptying Breath Test (GEBT). The test involves consuming a small amount of Spirulina labeled with a stable isotope of carbon, followed by breathing into a machine that measures the amount of carbon dioxide in the breath. The rate of carbon dioxide production is then used to calculate the rate of food emptying from the stomach. The GEBT is a safe, standardized, and convenient alternative to nuclear medicine-based gastric emptying evaluations typically conducted in a nuclear medicine center. The test can be administered in a clinical setting or via telehealth at a patient’s home and is a non-invasive tool for measuring gastric emptying velocity and aiding in the diagnosis of gastroparesis.
The dumping syndrome market covered in this report is segmented –
1) By Diagnosis: Blood Sugar Test; Gastric Emptying Test; Medical History; Other Diagnosis
2) By Treatment: Medication; Surgery; Other Treatments
3) By Route Of Administration: Oral; Intravenous; Other Routes Of Administration
4) By Phase: Early Dumping Phase; Late Dumping Phase
5) By End User: Hospitals And Clinics; Research Laboratories; Other End Users
Get an inside scoop of the dumping syndrome market, Request now for Sample Report @
https://www.thebusinessresearchcompany.com/sample.aspx?id=12991&type=smp
Regional Insights –
North America was the largest region in the dumping syndrome market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in dumping syndrome market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
Key Companies –
Major players in the dumping syndrome market are Cardinal Health Inc., Johnson & Johnson Private Limited, Abbott Laboratories Inc., Medtronic PLC, Covidien PLC, Fujifilm Holdings Corporation, Stryker Corporation, Allergan PLC, Boston Scientific Corporation, B. Braun Melsungen AG, Olympus Corporation, Intuitive Surgical Inc., Terumo Corporation, Steris Corporation, Teleflex Medical Europe Ltd., Cook Medical Inc., Karl Storz SE & Co. KG, Conmed Corporation, Applied Medical Resources Corporation, Richard Wolf GmbH, Pentax Medical Company, GI Dynamics, EndoGastric Solutions Inc., Apollo Endosurgery Inc., EndoChoice Holdings Inc., Cousin Biotech , Mediflex Surgical Product, Asensus Surgical Inc., USGI Medical Inc., TransEnterix Inc.
Table of Contents
1. Executive Summary
2. Dumping Syndrome Market Report Structure
3. Dumping Syndrome Market Trends And Strategies
4. Dumping Syndrome Market – Macro Economic Scenario
5. Dumping Syndrome Market Size And Growth
…..
27. Dumping Syndrome Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
